Jove
Visualize
Contact Us

Related Experiment Videos

Cationic antimicrobial peptides : issues for potential clinical use.

Jeremy Bradshaw1

  • 1Department of Preclinical Veterinary Sciences, Royal (Dick) School of Veterinary Studies, University of Edinburgh, Edinburgh, Scotland, UK. j.bradshaw@ed.ac.uk

Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|August 6, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-World Views of Patching Differ to Health Professionals': An Online Survey of Professionals, Patients, Teachers, Parents and Carers.

The British and Irish orthoptic journal·2025
Same author

Children's visual acuity tests without professional supervision: a prospective repeated measures study.

Eye (London, England)·2023
Same author

Can the Cellular Internalization of Cargo Proteins Be Enhanced by Fusing a Tat Peptide in the Center of Proteins? A Fluorescence Study.

Journal of pharmaceutical sciences·2017
Same author

Efficient internalization of TAT peptide in zwitterionic DOPC phospholipid membrane revealed by neutron diffraction.

Biochimica et biophysica acta. Biomembranes·2017
Same author

Topical application of superoxide dismutase mediated by HIV-TAT peptide attenuates UVB-induced damages in human skin.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2016
Same author

Insertion of TAT peptide and perturbation of negatively charged model phospholipid bilayer revealed by neutron diffraction.

Biochimica et biophysica acta·2013
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Antimicrobial peptides are natural defenses that kill microbes by disrupting membranes. Optimizing their design for clinical use faces challenges like cost and toxicity, though some are already in use.

Area of Science:

  • Biochemistry and Molecular Biology
  • Microbiology
  • Drug Discovery

Background:

  • Antimicrobial peptides (AMPs) are crucial defense molecules found across diverse organisms.
  • These peptides, typically 20-40 amino acids long, exhibit broad-spectrum antimicrobial activity.
  • Their classification is based on distinct structural conformations, influencing their mechanism of action.

Purpose of the Study:

  • To explore the mechanisms by which AMPs kill microbial cells, particularly bacteria.
  • To investigate the structural features governing AMP selectivity and membrane disruption.
  • To assess the potential and challenges of developing AMPs for clinical applications.

Main Methods:

  • Review of existing literature on AMP structure-activity relationships.

Related Experiment Videos

  • Analysis of proposed mechanisms of bacterial membrane disruption by AMPs (e.g., pore formation, carpet mechanism).
  • Examination of factors influencing AMP efficacy, selectivity, and potential for resistance development.
  • Main Results:

    • AMPs are believed to kill bacteria by disrupting cell membranes, with proposed mechanisms including pore formation and membrane aggregation.
    • Selectivity for prokaryotic over eukaryotic cells is linked to membrane differences.
    • Several AMPs, such as nisin and polymyxin B, are already in clinical or commercial use.

    Conclusions:

    • AMPs represent promising candidates for new therapeutics due to their rapid action and potential to overcome bacterial resistance.
    • Significant challenges remain in optimizing AMPs for clinical use, including production costs, toxicity, and proteolytic degradation.
    • Despite initial optimism, bacterial resistance to AMPs is an emerging concern, necessitating further research and development.